ArticleMolecular oncology2024

RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.